Karyopharm Therapeutics
KPTI
#9058
Rank
HK$1.02 B
Marketcap
HK$45.53
Share price
-0.17%
Change (1 day)
65.24%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2025

Volume in USD (price x number of shares), data since 2025

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$1.29 M-87.39%
2025HK$10.27 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
HK$10.98 MHK$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$0.12 BHK$0.18 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$42.45 MHK$72.09 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$17.17 MHK$30.66 M๐Ÿ‡บ๐Ÿ‡ธ USA